Twist Bioscience Corporation (BIT:1TWST)
41.23
-0.27 (-0.65%)
At close: Feb 11, 2026
Twist Bioscience Revenue
Twist Bioscience had revenue of $103.70M USD in the quarter ending December 31, 2025, with 16.89% growth. This brings the company's revenue in the last twelve months to $391.56M, up 18.59% year-over-year. In the fiscal year ending September 30, 2025, Twist Bioscience had annual revenue of $376.57M with 20.32% growth.
Revenue (ttm)
$391.56M
Revenue Growth
+18.59%
P/S Ratio
7.69
Revenue / Employee
$399.96K
Employees
979
Market Cap
2.57B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 376.57M | 63.60M | 20.32% |
| Sep 30, 2024 | 312.97M | 67.87M | 27.69% |
| Sep 30, 2023 | 245.11M | 41.54M | 20.41% |
| Sep 30, 2022 | 203.57M | 71.23M | 53.83% |
| Sep 30, 2021 | 132.33M | 42.23M | 46.87% |
| Sep 30, 2020 | 90.10M | 35.72M | 65.67% |
| Sep 30, 2019 | 54.39M | - | - |
| Jun 30, 2019 | 54.39M | 28.96M | 113.89% |
| Sep 30, 2018 | 25.43M | - | - |
| Jun 30, 2018 | 25.43M | 14.66M | 136.16% |
| Sep 30, 2017 | 10.77M | 8.50M | 374.53% |
| Sep 30, 2016 | 2.27M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Webuild | 12.15B |
| Iren SpA | 6.69B |
| Brembo | 3.75B |
| MFE-Mediaforeurope | 2.88B |
| Ariston Holding | 2.68B |
| Amplifon | 2.41B |
| Cementir Holding | 1.67B |
| ENAV S.p.A. | 989.17M |